Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use OMLONTI ® safely and effectively. See full prescribing information for OMLONTI ®. OMLONTI ® (omidenepag isopropyl ophthalmic solution) 0.002%, for topical ophthalmic use Initial U.S. Approval: 2022
Medication labelWhy this: Advisory · dailymed-prescription
Omlonti (omidenepag isopropyl ophthalmic solution) 0.002%, is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
- generic_name
- omidenepag isopropyl
- product_names
- omidenepag isopropyl
- ndc
- 65086-002, 65086-002-05, 65086-002-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en